NTK Institute Logo Mission Statement - Dedicated to improving medical practice through the immediate delivery of new clinically-relevant science to physicians who most urgently need to know about this science Need-To-Know Science Scoring System
About The Institute
NTK Initiative
NTK Watch
Recently Scored Science
Contact Us
To sign up to receive the NTK Watch daily e-mail
All alendronate News
07/28/2015 Effects of teriparatide retreatment in a patient with ?-thalassemia major (Transfusion)
07/10/2015 Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially (J Bone Miner Res)
05/04/2015 Comparative Resistance to Teriparatide-Induced Bone Resorption with Denosumab or Alendronate (J Clin Endocrinol Metab)
03/30/2015 Patient preference for monthly bisphosphonate versus weekly bisphosphonate in a cluster-randomized, open-label, crossover trial: Minodroate Alendronate/Risedronate Trial in Osteoporosis (MARTO) (J Bone Miner Metab)
03/27/2015 Pharmacological interventions for pain in children and adolescents with life-limiting conditions (Cochrane Database Syst Rev)
02/06/2015 Bisphosphonate-related osteonecrosis of the palatal torus (ORL, Journal of Oto-Rhino-Laryngology and Its Related Specialties)
01/29/2015 Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis (Osteoporos Int)
01/14/2015 Treatment of primary osteoporosis in men (Clin Interv Aging)
12/31/2014 Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover (Aging Clin Exp Res)
12/16/2014 Current and future treatments of osteoporosis in men (Best Pract Res Clin Endocrinol Metab)
12/04/2014 Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference (J Endocrinol Invest)
11/19/2014 Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures (Clin Rheumatol)
10/30/2014 Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches (Curr Osteoporos Rep)
10/21/2014 Bisphosphonate-Induced Cutaneous Adverse Events: The Difficulty of Assessing Imputability through Patch Testing (Dermatology)
10/20/2014 Is There Enough Evidence to Use Bisphosphonates in HIV-Infected Patients? A Systematic Review and Meta-analysis (AIDS Rev)
08/19/2014 Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer: Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid (JAMA Intern Med)
07/07/2014 The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment (Aging Clin Exp Res)
05/30/2014 Incidence and Risk of Venous Thromboembolism Among Taiwan Osteoporotic Fracture Population under Osteoporosis Pharmacological Treatments (J Clin Endocrinol Metab)
05/13/2014 Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy: The FLEX Study (JAMA Intern Med)
05/06/2014 Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials (J Bone Miner Metab)
04/29/2014 Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis (Osteoporos Int)
04/17/2014 The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate (Bone)
04/11/2014 Fracture Risk Reduction with Denosumab in Japanese Postmenopausal Women and Men with Osteoporosis: Denosumab fracture Intervention RandomizEd placebo Controlled Trial (DIRECT) (J Clin Endocrinol Metab)
04/08/2014 Established and forthcoming drugs for the treatment of osteoporosis (Curr Opin Rheumatol)
04/03/2014 Use of strontium ranelate and risk of acute coronary syndrome: cohort study (Ann Rheum Dis)
04/01/2014 Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis (J Clin Pharm Ther)
03/27/2014 External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review (Osteoporos Int)
03/27/2014 Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy (Rheumatol Int)
03/26/2014 The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab (Gynecol Endocrinol)
03/24/2014 Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis (Menopause)


 1  2  3     Next


Copyright © 2015, NTK Institute |  Terms and Conditions  |  Privacy Policy